| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |